T. Rowe Price Associates’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,216,500
| Closed | -$3.27M | – | 2934 |
|
|
2023
Q3 | $3.27M | Sell |
1,216,500
-39,509
| -3% | -$106K | ﹤0.01% | 1297 |
|
|
2023
Q2 | $11.7M | Sell |
1,256,009
-69,556
| -5% | -$649K | ﹤0.01% | 1048 |
|
|
2023
Q1 | $11.8M | Buy |
1,325,565
+11,657
| +0.9% | +$104K | ﹤0.01% | 1028 |
|
|
2022
Q4 | $6.54M | Sell |
1,313,908
-67,581
| -5% | -$337K | ﹤0.01% | 1128 |
|
|
2022
Q3 | $8.01M | Sell |
1,381,489
-3,794
| -0.3% | -$22K | ﹤0.01% | 1101 |
|
|
2022
Q2 | $7.66M | Sell |
1,385,283
-51,333
| -4% | -$284K | ﹤0.01% | 1357 |
|
|
2022
Q1 | $16.3M | Buy |
1,436,616
+137,129
| +11% | +$1.56M | ﹤0.01% | 1282 |
|
|
2021
Q4 | $16.2M | Buy |
+1,299,487
| New | +$16.2M | ﹤0.01% | 1331 |
|